{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T15:57:12Z","timestamp":1765727832212},"reference-count":29,"publisher":"Japanese Circulation Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2017]]},"DOI":"10.1253\/circj.cj-16-0957","type":"journal-article","created":{"date-parts":[[2017,1,18]],"date-time":"2017-01-18T22:09:41Z","timestamp":1484777381000},"page":"511-519","source":"Crossref","is-referenced-by-count":7,"title":["Association Between Prior Aspirin Use and Morphological Features of Culprit Lesions at First Presentation of Acute Coronary Syndrome Assessed by Optical Coherence Tomography"],"prefix":"10.1253","volume":"81","author":[{"given":"Taishi","family":"Yonetsu","sequence":"first","affiliation":[{"name":"Division of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsumin","family":"Lee","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Foundation"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Murai","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinori","family":"Kanno","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rikuta","family":"Hamaya","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadamitsu","family":"Ichijo","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Niida","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Hada","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Araki","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junji","family":"Matsuda","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eisuke","family":"Usui","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Hoshino","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihisa","family":"Kanaji","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsunekazu","family":"Kakuta","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes (2). <i>N Engl J Med<\/i> 1992; 326: 310\u2013318.","DOI":"10.1056\/NEJM199201303260506"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Antithrombotic Trialists\u2019 (ATT) Collaboration, Baigent C, Blackwell L, Collins R, Emberson J, Godwin J, Peto R, et al. Aspirin in the primary and secondary prevention of vascular disease: Collaborative meta-analysis of individual participant data from randomised trials. <i>Lancet<\/i> 2009; 373: 1849\u20131860.","DOI":"10.1016\/S0140-6736(09)60503-1"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Amsterdam EA, Wenger NK, Brindis RG, Casey DE Jr, Ganiats TG, Holmes DR Jr, et al. 2014 AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. <i>Circulation<\/i> 2014; 130: e344\u2013e426.","DOI":"10.1161\/CIR.0000000000000134"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Alexander JH, Harrington RA, Tuttle RH, Berdan LG, Lincoff AM, Deckers JW, et al. Prior aspirin use predicts worse outcomes in patients with non-ST-elevation acute coronary syndromes: PURSUIT Investigators: Platelet IIb\/IIIa in Unstable angina: Receptor Suppression Using Integrilin Therapy. <i>Am J Cardiol<\/i> 1999; 83: 1147\u20131151.","DOI":"10.1016\/S0002-9149(99)00049-1"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Lancaster GI, Lancaster CJ, Radley D, Cohen M. Prior aspirin use in unstable angina predisposes to higher risk: The aspirin paradox. <i>Int J Cardiol<\/i> 2001; 80: 201\u2013207.","DOI":"10.1016\/S0167-5273(01)00495-8"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Rich JD, Cannon CP, Murphy SA, Qin J, Giugliano RP, Braunwald E. Prior aspirin use and outcomes in acute coronary syndromes. <i>J Am Coll Cardiol<\/i> 2010; 56: 1376\u20131385.","DOI":"10.1016\/j.jacc.2010.06.028"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Ogawa H, Nakayama M, Morimoto T, Uemura S, Kanauchi M, Doi N, et al. Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: A randomized controlled trial. <i>JAMA<\/i> 2008; 300: 2134\u20132141.","DOI":"10.1001\/jama.2008.623"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Belch J, MacCuish A, Campbell I, Cobbe S, Taylor R, Prescott R, et al. The prevention of progression of arterial disease and diabetes (POPADAD) trial: Factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease. <i>BMJ<\/i> 2008; 337: a1840.","DOI":"10.1136\/bmj.a1840"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Tearney GJ, Regar E, Akasaka T, Adriaenssens T, Barlis P, Bezerra HG, et al. Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: A report from the International Working Group for Intravascular Optical Coherence Tomography Standardization and Validation. <i>J Am Coll Cardiol<\/i> 2012; 59: 1058\u20131072.","DOI":"10.1016\/j.jacc.2011.09.079"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, et al. Third universal definition of myocardial infarction. <i>J Am Coll Cardiol<\/i> 2012; 60: 1581\u20131598.","DOI":"10.1016\/j.jacc.2012.08.001"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Antman EM, McCabe CH, Gurfinkel EP, Turpie AG, Bernink PJ, Salein D, et al. Enoxaparin prevents death and cardiac ischemic events in unstable angina\/non-Q-wave myocardial infarction: Results of the thrombolysis in myocardial infarction (TIMI) 11B trial. <i>Circulation<\/i> 1999; 100: 1593\u20131601.","DOI":"10.1161\/01.CIR.100.15.1593"},{"key":"12","unstructured":"12. Brener SJ, Maehara A, Mintz GS, Weisz G, de Bruyne B, Serruys PW, et al. Effect of prior aspirin treatment on patients with acute coronary syndromes: Insights from the PROSPECT study. <i>J Invasive Cardiol<\/i> 2015; 27: 536\u2013541."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J, et al. Standardized bleeding definitions for cardiovascular clinical trials: A consensus report from the Bleeding Academic Research Consortium. <i>Circulation<\/i> 2011; 123: 2736\u20132747.","DOI":"10.1161\/CIRCULATIONAHA.110.009449"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Prati F, Cera M, Ramazzotti V, Imola F, Giudice R, Giudice M, et al. From bench to bedside: A novel technique of acquiring OCT images. <i>Circ J<\/i> 2008; 72: 839\u2013843.","DOI":"10.1253\/circj.72.839"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Prati F, Cera M, Ramazzotti V, Imola F, Giudice R, Albertucci M. Safety and feasibility of a new non-occlusive technique for facilitated intracoronary optical coherence tomography (OCT) acquisition in various clinical and anatomical scenarios. <i>EuroIntervention<\/i> 2007; 3: 365\u2013370.","DOI":"10.4244\/EIJV3I3A66"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Prati F, Guagliumi G, Mintz GS, Costa M, Regar E, Akasaka T, et al. Expert review document. Part 2: Methodology, terminology and clinical applications of optical coherence tomography for the assessment of interventional procedures. <i>Eur Heart J<\/i> 2012; 33: 2513\u20132520.","DOI":"10.1093\/eurheartj\/ehs095"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Prati F, Regar E, Mintz GS, Arbustini E, Di Mario C, Jang IK, et al. Expert review document on methodology, terminology, and clinical applications of optical coherence tomography: Physical principles, methodology of image acquisition, and clinical application for assessment of coronary arteries and atherosclerosis. <i>Eur Heart J<\/i> 2010; 31: 401\u2013415.","DOI":"10.1093\/eurheartj\/ehp433"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Higuma T, Soeda T, Yamada M, Yokota T, Yokoyama H, Izumiyama K, et al. Does Residual thrombus after aspiration thrombectomy affect the outcome of primary PCI in patients with ST-segment elevation myocardial infarction?: An optical coherence tomography study. <i>JACC Cardiovasc Interv<\/i> 2016; 9: 2002\u20132011.","DOI":"10.1016\/j.jcin.2016.06.050"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Kajander OA, Koistinen LS, Eskola M, Huhtala H, Bhindi R, Niemela K, et al. Feasibility and repeatability of optical coherence tomography measurements of pre-stent thrombus burden in patients with STEMI treated with primary PCI. <i>Eur Heart J Cardiovasc Imaging<\/i> 2015; 16: 96\u2013107.","DOI":"10.1093\/ehjci\/jeu175"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Ryan TJ, Faxon DP, Gunnar RM, Kennedy JW, King SB 3rd, Loop FD, et al. Guidelines for percutaneous transluminal coronary angioplasty: A report of the American College of Cardiology\/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty). <i>Circulation<\/i> 1988; 78: 486\u2013502.","DOI":"10.1161\/01.CIR.78.2.486"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Patrono C, Garcia Rodriguez LA, Landolfi R, Baigent C. Low-dose aspirin for the prevention of atherothrombosis. <i>N Engl J Med<\/i> 2005; 353: 2373\u20132383.","DOI":"10.1056\/NEJMra052717"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Monobe H, Yamanari H, Nakamura K, Ohe T. Effects of low-dose aspirin on endothelial function in hypertensive patients. <i>Clin Cardiol<\/i> 2001; 24: 705\u2013709.","DOI":"10.1002\/clc.4960241104"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Noon JP, Walker BR, Hand MF, Webb DJ. Impairment of forearm vasodilatation to acetylcholine in hypercholesterolemia is reversed by aspirin. <i>Cardiovasc Res<\/i> 1998; 38: 480\u2013484.","DOI":"10.1016\/S0008-6363(98)00013-3"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Voisard R, Fischer R, Osswald M, Voglic S, Baur R, Susa M, et al. Aspirin (5 mmol\/L) inhibits leukocyte attack and triggered reactive cell proliferation in a 3D human coronary in vitro model. <i>Circulation<\/i> 2001; 103: 1688\u20131694.","DOI":"10.1161\/01.CIR.103.12.1688"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Virmani R, Burke AP, Farb A, Kolodgie FD. Pathology of the vulnerable plaque. <i>J Am Coll Cardiol<\/i> 2006; 47: C13\u2013C18.","DOI":"10.1016\/j.jacc.2005.10.065"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Jia H, Abtahian F, Aguirre AD, Lee S, Chia S, Lowe H, et al. In vivo diagnosis of plaque erosion and calcified nodule in patients with acute coronary syndrome by intravascular optical coherence tomography. <i>J Am Coll Cardiol<\/i> 2013; 62: 1748\u20131758.","DOI":"10.1016\/j.jacc.2013.05.071"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Spencer FA, Santopinto JJ, Gore JM, Goldberg RJ, Fox KA, Moscucci M, et al. Impact of aspirin on presentation and hospital outcomes in patients with acute coronary syndromes (The Global Registry of Acute Coronary Events [GRACE]). <i>Am J Cardiol<\/i> 2002; 90: 1056\u20131061.","DOI":"10.1016\/S0002-9149(02)02769-8"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Portnay EL, Foody JM, Rathore SS, Wang Y, Masoudi FA, Curtis JP, et al. Prior aspirin use and outcomes in elderly patients hospitalized with acute myocardial infarction. <i>J Am Coll Cardiol<\/i> 2005; 46: 967\u2013974.","DOI":"10.1016\/j.jacc.2005.06.049"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, et al. From vulnerable plaque to vulnerable patient: A call for new definitions and risk assessment strategies: Part I. <i>Circulation<\/i> 2003; 108: 1664\u20131672.","DOI":"10.1161\/01.CIR.0000087480.94275.97"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/81\/4\/81_CJ-16-0957\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T08:34:09Z","timestamp":1498379649000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/81\/4\/81_CJ-16-0957\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-16-0957","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}